MoneyWorks4Me

A decrease in the sales to Rs. 748.93 millions was observed for the quarter ended March 2025. The sales stood at Rs. 890.58 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2025 is Rs. -103.28 millions as compared to Net Profit of Rs. 129.12 millions of corresponding quarter ended March 2024Operating profit Margin for the quarter ended March 2025 slipped to -98.59% as compared to 200.12% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 748.93 890.58 -15.91 3457.68 3624.62 -4.61 3457.68 3624.62 -4.61
Other Income -51.14 104.43 -148.97 295.81 575.52 -48.60 295.81 575.52 -48.60
PBIDT -98.59 200.12 -149.27 326.07 1044.32 -68.78 326.07 1044.32 -68.78
Interest 1.32 0.68 94.12 4.10 3.21 27.73 4.10 3.21 27.73
PBDT -99.91 199.44 -150.10 321.97 1041.11 -69.07 321.97 1041.11 -69.07
Depreciation 18.18 18.30 -0.66 69.69 68.25 2.11 69.69 68.25 2.11
PBT -118.09 181.14 -165.19 252.28 972.86 -74.07 252.28 972.86 -74.07
TAX -14.81 52.02 -128.47 80.27 218.66 -63.29 80.27 218.66 -63.29
Deferred Tax -32.69 8.85 -469.38 21.03 42.76 -50.82 21.03 42.76 -50.82
PAT -103.28 129.12 -179.99 172.01 754.20 -77.19 172.01 754.20 -77.19
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) -13.16 22.47 -158.58 9.43 28.81 -67.27 9.43 28.81 -67.27
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..